According to a recent LinkedIn post from Zorro, the company is promoting an upcoming live session focused on selling Individual Coverage Health Reimbursement Arrangements, or ICHRA. The post highlights that Jeff Kirchick, Zorro’s VP of Sales and an author on sales practices, will lead a session aimed at helping brokers navigate stalled and complex ICHRA deals more effectively.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests the event will cover how to identify high-fit ICHRA opportunities, diagnose why deals stall, and use discovery to uncover decision drivers in employer benefits decisions. For investors, this emphasis on broker education may signal Zorro’s strategy to deepen its distribution footprint in the ICHRA segment, potentially supporting higher deal conversion rates and more predictable sales cycles over time.
By positioning the session as highly practical and geared toward top-performing brokers, Zorro appears to be targeting more sophisticated intermediaries who can move meaningful volumes of business. If effective, this focus on sales enablement could enhance Zorro’s competitive positioning in the growing ICHRA market, where broker relationships and execution quality are likely to be key differentiators for revenue growth and customer acquisition efficiency.

